500-Patient registry aims to unlock secrets of rare disease amyloidosis
NCT ID NCT01347047
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study is creating a registry of 500 people with amyloidosis at Hospital Italiano de Buenos Aires. Researchers will track risk factors, diagnosis, treatment, and survival over time to better understand the disease. No new treatments are being tested—this is purely an observational study to gather information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, C1199, Argentina
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A hidden warning in your wrist? surgery may reveal heart risk
- Can a daily pill keep a rare heart disease in check for the long haul?
- Heart drug acoramidis tested for Long-Term cardiac repair in rare amyloidosis
- App-Based diet tracking tested in rare disease
- Hidden amyloid in heart valves: a new clue in aortic stenosis?
- New nerve patch could ease pain after biopsy